Becton, Dickinson and Co. | BDX - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 3.6B 330M 2026-06
Agilent USD 465M 11M 2026-03
Align Technology USD 462.67M 2.67M 2026-06
AngioDynamics USD 36.57M 3.79M 2025-09
Baxter International USD 735M 7M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Bio-Rad Laboratories USD 212M 400K 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Cooper Companies USD 676.2M 303.1M 2026-03
Danaher USD 2.07B 212M 2026-06
Dentsply International USD 364M 13M 2026-06
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Globus Medical USD 286.82M 10.95M 2026-06
Insulet USD 344.8M 27.6M 2026-06
Integra LifeSciences USD 166.22M 12.01M 2026-06
Intuitive Surgical USD 617.9M 4.6M 2026-06
J&J USD 6.42B 381M 2026-06
Medtronic 2.96B 9M 2025-12
Solventum Corp USD 927M 144M 2026-06
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 111.64M 3.45M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
Terumo JPY 109.7B 5.11B 2026-06
Thermo Fisher Scientific USD 1.91B 111M 2026-06
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06